In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

about

21-year retrospective study of the prevalence of Scopulariopsis brevicaulis in patients suspected of superficial mycoses.In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species

P2860

Q35829094-93FE88B3-0287-4C91-A0C2-3327FBB30551 Q35960992-4A4D5011-FA4F-4368-90FB-A22994806D93

P2860

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

Item

http://www.wikidata.org/entity/Q46863305

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@en

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@nl

type

Item

label

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@en

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@nl

prefLabel

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@en

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@nl

P1476

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

@en

P2093

Anna B Macura

http://www.w3.org/2001/XMLSchema#string

Magdalena Skóra

http://www.w3.org/2001/XMLSchema#string

Małgorzata Bulanda

http://www.w3.org/2001/XMLSchema#string

P2860

Occurrence of Scopulariopsis and Scedosporium in nails and keratinous skin. A 5-year retrospective multi-center study.

Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.

Onychomycosis caused by Scopulariopsis brevicaulis: report of two cases

Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature.

Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.

Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.

In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.

P304

723-727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/MMY/MYU039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264125996

http://www.w3.org/2001/XMLSchema#string

P698

25049036

http://www.w3.org/2001/XMLSchema#string

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

about

P2860

P2860

In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698